How it works:
Replenishes synovial fluid in the joint
Reduces mechanical friction and eases movement
Exhibits anti-inflammatory and analgesic effects
Improves joint functionality and range of motion
Recommended for:
Patients with osteoarthritis (especially knee)
Individuals with joint pain and stiffness
Patients who cannot tolerate NSAIDs
As part of comprehensive osteoarthritis treatment
Symptomatic treatment of osteoarthritis (knee, hip, shoulder), reducing pain and improving joint mobility.
HYALGAN is administered via intra-articular injection and must be performed exclusively by a qualified healthcare professional. The standard treatment regimen involves one injection into the affected joint once per week. The course of therapy typically consists of 3–5 injections and is determined by the physician based on the severity of joint damage and the patient’s clinical response to treatment.
If necessary, excess synovial fluid may be aspirated from the joint cavity prior to administration. The injection must be carried out under strict sterile conditions and in accordance with proper intra-articular injection techniques. Self-administration of the medication is not recommended.
Contraindications:
Known hypersensitivity to hyaluronic acid
Infection at injection site
Active joint inflammation
Pregnancy and breastfeeding
Children under 18 (safety not established)
Side effects:
Temporary joint pain and swelling
Redness and warmth at injection site
Allergic reactions
Rarely: septic arthritis
